Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii

Plant Biotechnology Journal

Volumn 15, Issue 9, 2017, Pages 1130-1140

  Stoffels, Laura ^a   Taunt, Henry N ^a,c   Charalambous, Bambos ^b   Purton, Saul ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Algenuity   (United Kingdom)

Author keywords

antimicrobials; Chlamydomonas reinhardtii; chloroplast; Cpl 1; endolysin; Pal

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; ENDOLYSIN; PROTEINASE; RECOMBINANT PROTEIN;

BACTERIOPHAGE; CELL WALL; CHLAMYDOMONAS REINHARDTII; CHLOROPLAST; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; STREPTOCOCCUS PNEUMONIAE; TRANSGENIC PLANT;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOPHAGES; CELL WALL; CHLAMYDOMONAS REINHARDTII; CHLOROPLASTS; ENDOPEPTIDASES; HUMANS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; STREPTOCOCCUS PNEUMONIAE;

EID: 85014609775     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12703     Document Type: Article

References (66)

1. Abedon, S.T. (2008) Bacteriophage Ecology: Population Growth, Evolution, and Impact of Bacterial Viruses. Cambridge: Cambridge University Press.
2. Adam, Z., Rudella, A. and van Wijk, K.J. (2006) Recent advances in the study of Clp, FtsH and other proteases located in chloroplasts. Curr. Opin. Plant Biol. 9, 234–240.
3. Almaraz-Delgado, A.L., Flores-Uribe, J., Pérez-España, V.H., Salgado-Manjarrez, E. and Badillo-Corona, J.A. (2014) Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii. AMB Express, 4, 57.
4. Andersen, D.C. and Krummen, L. (2002) Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 13, 117–123.
5. Barrera, D.J. and Mayfield, S.P. (2013) High-value recombinant protein production in microalgae. In: Handbook of Microalgal Culture (Richmond, A. and Hu, Q. eds), pp. 532–544. New Jersey: John Wiley and Sons, Ltd.
6. Blaser, M. (2011) Antibiotic overuse: stop the killing of beneficial bacteria. Nature, 476, 393–394.
7. Bock, R. (2015) Engineering plastid genomes: methods, tools, and applications in basic research and biotechnology. Annu. Rev. Plant Biol. 66, 211–241.
8. Bock, R. and Warzecha, H. (2010) Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol. 28, 246–252.
9. Borysowski, J., Weber-Dąbrowska, B. and Górski, A. (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp. Biol. Med. 231, 366–377.
10. Briers, Y., Walmagh, M., Puyenbroeck, V.V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H. et al. (2014) Engineered endolysin-based “artilysins” to combat multidrug-resistant Gram-negative pathogens. mBio, 5, e01379–14.
11. Chen, Y. and Blaser, M.J. (2007) Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 167, 821–827.
12. Daniell, H., Lin, C.S., Yu, M. and Chang, W.J. (2016) Chloroplast genomes: diversity, evolution, and applications in genetic engineering. Genome Biol. 17, 134.
13. Douchi, D., Qu, Y., Longoni, P., Legendre-Lefebvre, L., Johnson, X., Schmitz-Linneweber, C. and Goldschmidt-Clermont, M. (2016) A nucleus-encoded chloroplast phosphoprotein governs expression of the photosystem I subunit PsaC in Chlamydomonas reinhardtii. Plant Cell, 28, 1182–1199.
14. Dove, A. (2002) Uncorking the biomanufacturing bottleneck. Nat. Biotechnol. 20, 777–779.
15. Dreesen, I.A.J., Hamri, G.C.-E. and Fussenegger, M. (2010) Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J. Biotechnol. 145, 273–280.
16. Economou, C., Wannathong, T., Szaub, J. and Purton, S. (2014) A simple, low-cost method for chloroplast transformation of the green alga Chlamydomonas reinhardtii. In Chloroplast Biotechnology (Maliga, P. ed), pp. 401–411. New York: Humana Press.
17. Entenza, J.M., Loeffler, J.M., Grandgirard, D., Fischetti, V.A. and Moreillon, P. (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob. Agents Chemother. 49, 4789–4792.
18. Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M. and Drossard, J. (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv. 30, 434–439.
19. Fuhrmann, M., Oertel, W. and Hegemann, P. (1999) A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii. Plant J. 19, 353–361.
20. Garcia, P., Garcia, E., Ronda, C., Lopez, R. and Tomasz, A. (1983) A phage-associated murein hydrolase in Streptococcus pneumoniae infected with bacteriophage Dp-1. J. Gen. Microbiol. 129, 489–497.
21. Ghasemi, Y., Moradian, A., Mohagheghzadeh, A., Shokravi, S. and Morowvat, M.H. (2007) Antifungal and antibacterial activity of the microalgae collected from paddy fields of Iran: characterization of antimicrobial activity of Chroococcus dispersus. J. Biol. Sci. 7, 904–910.
22. Gimpel, J.A., Hyun, J.S., Schoepp, N.G. and Mayfield, S.P. (2014) Production of recombinant proteins in microalgae at pilot greenhouse scale. Biotechnol. Bioeng. 112, 339–345.
23. Grandgirard, D., Loeffler, J.M., Fischetti, V.A. and Leib, S.L. (2008) Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J. Infect. Dis. 197, 1519–1522.
24. Gregory, J.A., Li, F., Tomosada, L.M., Cox, C.J., Topol, A.B., Vinetz, J.M. and Mayfield, S. (2012) Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission. PLoS ONE, 7, e37179.
25. Harris, E.H. (2009) The Chlamydomonas Sourcebook - Volume 1 - Introduction to Chlamydomonas and its Laboratory Use. Amsterdam: Elsevier.
26. He, D.-M., Qian, K.-X., Shen, G.-F., Zhang, Z.-F., Li, Y.-N., Su, Z.-L. and Shao, H.-B. (2007) Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chloroplasts. Colloids Surf. B Biointerfaces, 55, 26–30.
27. Infectious Diseases Society of America (IDSA) (2011) Combating antimicrobial resistance: policy recommendations to save lives. Clin. Infect. Dis. 52, S397–S428.
28. Jado, I., Lopez, R., Garcia, E., Fenoll, A., Casal, J. and Garcia, P. (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. Antimicrob. Chemother. 52, 967–973.
29. Jørgensen, E.G. (1962) Antibiotic substances from cells and culture solutions of unicellular algae with special reference to some chlorophyll derivatives. Physiol. Plant. 15, 530–545.
30. Jørgensen, C.M., Vrang, A. and Madsen, S.M. (2014) Recombinant protein expression in Lactococcus lactis using the P170 expression system. FEMS Microbiol. Lett. 351, 170–178.
31. Kindle, K.L. (1990) High-frequency nuclear transformation of Chlamydomonas reinhardtii. Proc. Natl Acad. Sci. USA, 87, 1228–1232.
32. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
33. Lee, S.-B., Li, B., Jin, S. and Daniell, H. (2011) Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol. J. 9, 100–115.
34. Lefebvre-Legendre, L., Choquet, Y., Kuras, R., Loubéry, S., Douchi, D. and Goldschmidt-Clermont, M. (2015) A nucleus-encoded chloroplast protein regulated by iron availability governs expression of the photosystem I subunit PsaA in Chlamydomonas reinhardtii. Plant Physiol. 167, 1527–1540.
35. Levy, S.B. (2005) Antibiotic resistance—the problem intensifies. Adv. Drug Deliv. Rev. 57, 1446–1450.
36. Levy, S.B. and Marshall, B. (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122–S129.
37. Loeffler, J.M. and Fischetti, V.A. (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob. Agents Chemother. 47, 375–377.
38. Loeffler, J.M., Nelson, D. and Fischetti, V.A. (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science, 294, 2170–2172.
39. Loessner, M. (2005) Bacteriophage endolysins — current state of research and applications. Curr. Opin. Microbiol. 8, 480–487.
40. Manuell, A.L., Beligni, M.V., Elder, J.H., Siefker, D.T., Tran, M., Weber, A., McDonald, T.L. et al. (2007) Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol. J. 5, 402–412.
41. Mellroth, P., Daniels, R., Eberhardt, A., Rönnlund, D., Blom, H., Widengren, J., Normark, S. et al. (2012) LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan. J. Biol. Chem. 287, 11018–11029.
42. Michelet, L., Lefebvre-Legendre, L., Burr, S.E., Rochaix, J.-D. and Goldschmidt-Clermont, M. (2011) Enhanced chloroplast transgene expression in a nuclear mutant of Chlamydomonas. Plant Biotechnol. J. 9, 565–574.
43. Nakamura, Y., Gojobori, T. and Ikemura, T. (2000) Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28, 292.
44. Oey, M., Lohse, M., Kreikemeyer, B. and Bock, R. (2009a) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. 57, 436–445.
45. Oey, M., Lohse, M., Scharff, L.B., Kreikemeyer, B. and Bock, R. (2009b) Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc. Natl Acad. Sci. USA, 106, 6579–6584.
46. Potvin, G. and Zhang, Z. (2010) Strategies for high-level recombinant protein expression in transgenic microalgae: a review. Biotechnol. Adv. 28, 910–918.
47. Preiss, S., Schrader, S. and Johanningmeier, U. (2001) Rapid, ATP-dependent degradation of a truncated D1 protein in the chloroplast. Eur. J. Biochem. 268, 4562–4569.
48. Rasala, B.A. and Mayfield, S.P. (2015) Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses. Photosynth. Res. 123, 227–239.
49. Rasala, B., Muto, M., Lee, P.A., Jager, M., Cardoso, R.M.F., Behnke, C.A., Kirk, P. et al. (2010) Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol. J. 8, 719–733.
50. Rodríguez-Cerrato, V., García, P., Del Prado, G., García, E., Gracia, M., Huelves, L., Ponte, C. et al. (2007) In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. J. Antimicrob. Chemother. 60, 1159–1162.
51. Sambrook, J. and Russell, D.W. (2001) Molecular Cloning. A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
52. Sanz, J.M., Lopez, R. and Garcia, J.L. (1988) Structural requirements of choline derivatives for “conversion” of pneumococcal amidase A new single-step procedure for purification of this autolysin. FEBS Lett. 232, 308–312.
53. Schmelcher, M., Donovan, D.M. and Loessner, M.J. (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 7, 1147–1171.
54. Schuch, R., Nelson, D. and Fischetti, V.A. (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature, 418, 884–889.
55. Shen, Y., Barros, M., Vennemann, T., Gallagher, D.T., Yin, Y., Linden, S.B. and Heselpoth, R.D. et al. (2016) A bacteriophage endolysin that eliminates intracellular streptococci. eLife, 5, e13152.
56. Specht, E.A. and Mayfield, S.P. (2013) Synthetic oligonucleotide libraries reveal novel regulatory elements in Chlamydomonas chloroplast mRNAs. ACS Synth. Biol. 2, 34–46.
57. Specht, E., Miyake-Stoner, S. and Mayfield, S. (2010) Micro-algae come of age as a platform for recombinant protein production. Biotechnol. Lett. 32, 1373–1383.
58. Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H.W., Scheld, W.M., Bartlett, J.G. et al. (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 46, 155–164.
59. Sun, M., Qian, K., Su, N., Chang, H., Liu, J., Shen, G. and Chen, G. (2003) Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol. Lett. 25, 1087–1092.
60. Tran, M., Henry, R.E., Siefker, D., Van, C., Newkirk, G., Kim, J., Bui, J. et al. (2013) Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners. Biotechnol. Bioeng. 110, 2826–2835.
61. Wannathong, T., Waterhouse, J.C., Young, R.E.B., Economou, C.K. and Purton, S. (2016) New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii. Appl. Microbiol. Biotechnol. 100, 5467–5477.
62. Werner, R. and Mergenhagen, D. (1998) Mating type determination of Chlamydomonas reinhardtii by PCR. Plant Mol. Biol. Rep. 16, 295–299.
63. WHO report (2014) WHO | Antimicrobial resistance: global report on surveillance 2014.
64. Wright, G.D. (2012) Antibiotics: a new hope. Chem. Biol. 19, 3–10.
65. Young, R.E.B. and Purton, S. (2014) Cytosine deaminase as a negative selectable marker for the microalgal chloroplast: a strategy for the isolation of nuclear mutations that affect chloroplast gene expression. Plant J. 80, 915–925.
66. Young, R., Wang, I.-N. and Roof, W.D. (2000) Phages will out: strategies of host cell lysis. Trends Microbiol. 8, 120–128.